Patent · US Active

Tricyclic compounds

US9365579B2 · kind B2 · utility

49Cited by
24References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2015
Grant dateJun 14, 2016
Priority date—
Expiry dateJan 30, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provide a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomer and isomer thereof wherein the variable are defined herein. The compound of the invention are useful for treating immunological and oncological conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.